Small Molecules

Enzyme engineering has opened up new possibilities in biocatalysis, but computational techniques and smart libraries also make wildtypes feasible. The choice is yours.

Why we shouldn’t forget gelatin’s longstanding reputation as a reliable and trusted excipient.

Gene encounters some challenges with chromatographic performance.

China is upping its game with plans to revolutionize its manufacturing industries, including pharma.

Catalysis is increasingly being adopted by pharma because it can bring down costs.

Drug emissions in UK rivers raise questions about long-term consequences for the environment.

The path to market for a biosimilar involves an abbreviated approval process, focused on proving “biosimilarity”.

A generic and inexpensive way to seperate chiral molecules: magnets

…and gives a Pint of Science presentation.

Celebrating the great and the good of pharma.